Predicting Prostate Cancer Risk Through Incorporation Of Prostate Cancer Gene 3
Oct 3rd 2008Drug InformationProstate
UroToday.com - Prostate cancer gene 3 is a promising new prostate cancer (CaP) biomarker as it is over-expressed in CaP tissue compared to normal prostate tissue. As such, Dr. Donna P. Ankerst and colleagues hypothesized that its inclusion in the Prostate Cancer Prevention Trial (PCPT) risk calculator may augment its predictive capabilities. Their research report appears in the October 2008 issue of the Journal of Urology.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
